Back

Mirabegron in peripheral vascular disease: the STAR-PAD trial.

28 August 2022 (17:15 - 17:30)
Organised by:
Congress Presentation Part of: Beta3 adrenergic agonists in the clinic: the end of the beginning Pharmacology and Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Michael Gray

St Leonards (United States of America)

3 More presentations in this session

Presentation thumbnail
Beta3 adrenergic receptors: where, and what for?
Professor J. Balligand (Brussels, BE)
Slides Video
Presentation thumbnail
Activation of beta3-AR with mirabegron in hypertrophic cardiomyopathy: the BETA3LVH trial.
Associate Professor R. Wachter (Leipzig, DE)
Slides Video
Presentation thumbnail
Mirabegron in patients with pulmonary hypertension: the SPHERE-HF trial.
Doctor A. Garcia-Alvarez (Barcelona, ES)
Slides Video

Access the full session

Session thumbnail
Beta3 adrenergic agonists in the clinic: the end of the beginning
Video

The Event

Event poster

ESC Congress 2022

28 August 2022 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Navigating lower limb PAD diagnosis and treatment
thumbnail
Webinar
Navigating diagnosis and management in peripheral artery disease with the latest guidelines
thumbnail
Congress Presentation
Evaluating the efficacy and safety of beta-3 adrenergic receptor agonists in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources